ICT&health July 2, 2025
During the ESOT conference 2025, a remarkable innovation was presented that could improve the future of diabetes care. An international team of scientists succeeded in using a specially developed bio-ink to 3D print functional human islets of insulin-producing cell clusters in the pancreas. This technology offers the prospect of safe, less invasive and personalised treatment for type 1 diabetes.
The islets were manufactured using a custom-made bio-ink based on alginate and decellularised human pancreatic tissue. This resulted in viable, functioning cell structures with a high density, which remained stable for up to three weeks. Under laboratory conditions, the printed islets responded effectively to glucose and released insulin adequately, highlighting their therapeutic potential.
Subcutaneous placement
What sets this approach apart is...
Today's Sponsors
Today's Sponsor